U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360158) titled 'BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs' on Jan. 14.
Brief Summary: The CorSky family is BIOTRONIK's new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features.
The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky).
The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
Study Start Date: June, 2026
Study Type: ...